SCHEMBL7867700

SCHEMBL7867700

CCOCCNC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.45
KMT2A Q03164 1/20 0.44
TSHR P16473 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
BLM P54132 2/20 0.44
CYP3A4 P08684 1/20 0.44
HTR1A P08908 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
NFKB1 P19838 1/20 0.44
CNR1 P21554 1/20 0.44
CYP2C19 P33261 1/20 0.44
ADRA1A P35348 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 1/20 0.42
THRB P10828 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7862846 0.92 LMNA (0.47) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7867896 0.89 LMNA (0.49) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7867703 0.88 EGFR (0.45) LMNAKMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL8867992 0.87 LMNA (0.51) LMNAKMT2ATSHRSMN1; SMN2BLM
SCHEMBL7874619 0.87 HPGD (0.47) LMNAKMT2ASMN1; SMN2MAPTHTT
SCHEMBL7862692 0.87 EGFR (0.43) LMNAKMT2ASMN1; SMN2MAPTCA12
SCHEMBL9574842 0.86 EGFR (0.43) KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL7869460 0.86 EGFR (0.43) KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL7874534 0.85 EGFR (0.42) LMNAKMT2ASMN1; SMN2MAPTCA12
SCHEMBL9018152 0.85 LMNA (0.49) LMNAKMT2ATSHRSMN1; SMN2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0562512-B1 Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines HOECHST AG (DE) 2001-02-21 EP disclosed
EP-0562512-A1 Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed